PT2651251T - Composição para o tratamento de distúrbios metabólicos - Google Patents

Composição para o tratamento de distúrbios metabólicos

Info

Publication number
PT2651251T
PT2651251T PT118133586T PT11813358T PT2651251T PT 2651251 T PT2651251 T PT 2651251T PT 118133586 T PT118133586 T PT 118133586T PT 11813358 T PT11813358 T PT 11813358T PT 2651251 T PT2651251 T PT 2651251T
Authority
PT
Portugal
Prior art keywords
infertility
treatment
composition
Prior art date
Application number
PT118133586T
Other languages
English (en)
Inventor
Amelotti Luigi
Secondini Lorenzo
Original Assignee
Laborest Italia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43736968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2651251(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laborest Italia S R L filed Critical Laborest Italia S R L
Publication of PT2651251T publication Critical patent/PT2651251T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT118133586T 2010-12-17 2011-12-19 Composição para o tratamento de distúrbios metabólicos PT2651251T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A002313A IT1403587B1 (it) 2010-12-17 2010-12-17 Composizione per il trattamento di disordini metabolici

Publications (1)

Publication Number Publication Date
PT2651251T true PT2651251T (pt) 2016-08-19

Family

ID=43736968

Family Applications (2)

Application Number Title Priority Date Filing Date
PT118133586T PT2651251T (pt) 2010-12-17 2011-12-19 Composição para o tratamento de distúrbios metabólicos
PT161711478T PT3081097T (pt) 2010-12-17 2011-12-19 Composição para o tratamento da infertilidade

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT161711478T PT3081097T (pt) 2010-12-17 2011-12-19 Composição para o tratamento da infertilidade

Country Status (12)

Country Link
EP (2) EP2651251B1 (pt)
BR (1) BR112013015048A2 (pt)
DK (2) DK3081097T3 (pt)
ES (2) ES2586930T3 (pt)
HR (1) HRP20160978T1 (pt)
HU (2) HUE047320T2 (pt)
IT (1) IT1403587B1 (pt)
PL (2) PL3081097T3 (pt)
PT (2) PT2651251T (pt)
RS (1) RS55057B1 (pt)
RU (1) RU2586742C2 (pt)
WO (1) WO2012080831A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2523660A4 (en) 2010-01-14 2013-07-10 Nuvo Res Inc FORMATION OF SOLID FORMS OF LOCAL ANESTHESIA FORMULATIONS FOR FIGHTING PAIN
ITMI20130349A1 (it) * 2013-03-07 2014-09-08 Laborest Italia S P A Composizione per uso nel trattamento della sindrome dell ovaio policistico
ITUA20163025A1 (it) 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
MX2021005888A (es) 2018-11-26 2021-06-23 Procter & Gamble Preparacion farmaceutica solida que contiene acido lipoico y uso de esta.
RU2757220C1 (ru) * 2020-06-03 2021-10-12 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2152787C2 (ru) * 1994-06-02 2000-07-20 Дан Рига Лекарство против стресса, против снижения уровня активности и против старения и способ его получения
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20070065456A1 (en) * 2005-09-20 2007-03-22 Woods Cindy J Nutritional supplements

Also Published As

Publication number Publication date
IT1403587B1 (it) 2013-10-31
RU2013130308A (ru) 2015-01-27
HRP20160978T1 (hr) 2016-10-07
BR112013015048A2 (pt) 2016-07-19
ES2586930T3 (es) 2016-10-19
PT3081097T (pt) 2020-01-14
PL3081097T3 (pl) 2020-06-15
EP3081097A1 (en) 2016-10-19
EP3081097B1 (en) 2019-12-04
EP2651251B1 (en) 2016-06-01
EP3081097B8 (en) 2020-01-08
HUE029493T2 (en) 2017-02-28
DK3081097T3 (da) 2020-01-20
RU2586742C2 (ru) 2016-06-10
PL2651251T3 (pl) 2017-06-30
ES2763437T3 (es) 2020-05-28
HUE047320T2 (hu) 2020-04-28
WO2012080831A1 (en) 2012-06-21
ITMI20102313A1 (it) 2012-06-18
DK2651251T3 (en) 2016-09-05
RS55057B1 (sr) 2016-12-30
EP2651251A1 (en) 2013-10-23

Similar Documents

Publication Publication Date Title
EP2554175A4 (en) COMPOSITION FOR THE TREATMENT OF A DESIRED PART
HK1218724A1 (zh) 用於治療瘻的組合物
PT2523661T (pt) Inibidores de nkcc para o tratamento de autismo
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
SI2635282T1 (sl) Sestavki za zdravljenje mielofibroze
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
PL2605764T3 (pl) Kompozycje do leczenia nowotworu
PT2651251T (pt) Composição para o tratamento de distúrbios metabólicos
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
EP2560679A4 (en) TREATMENT OF ECZEMA
EP2536436A4 (en) ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMICS
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
LT2460509T (lt) Kompozicija, skirta karpų gydymui
IL222072A (en) Composition for the treatment of primary thrombocythemia
PT2593423E (pt) Processo para a preparação de agentes de contraste
PT2390246T (pt) Processo para a preparação de aminaftona
PT2598504E (pt) Novo processo de fabrico de dimiracetam
IL223055A0 (en) Compositions for the treatment of gynaecological disorders
GB201007519D0 (en) Means for inhibiting the expression of rragb
GB201016836D0 (en) Composition for skin treatment
GB201016834D0 (en) Composition for skin treatment
GB201012310D0 (en) Composition for the treatment of botulism
IL224304A (en) A process for making dichlorobulben